CollPlant Biotechnologies (CLGN) FCF Margin (2018 - 2025)
Historic FCF Margin for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q3 2025 value amounting to 3735.06%.
- CollPlant Biotechnologies' FCF Margin rose 789649400.0% to 3735.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 399.03%, marking a year-over-year increase of 14965100.0%. This contributed to the annual value of 2642.72% for FY2024, which is 26262100.0% down from last year.
- Per CollPlant Biotechnologies' latest filing, its FCF Margin stood at 3735.06% for Q3 2025, which was up 789649400.0% from 1361.45% recorded in Q2 2025.
- In the past 5 years, CollPlant Biotechnologies' FCF Margin ranged from a high of 77.52% in Q1 2021 and a low of 82700.0% during Q3 2024
- Its 5-year average for FCF Margin is 7106.39%, with a median of 1428.92% in 2024.
- Per our database at Business Quant, CollPlant Biotechnologies' FCF Margin plummeted by -827000200bps in 2024 and then skyrocketed by 789649400bps in 2025.
- CollPlant Biotechnologies' FCF Margin (Quarter) stood at 320.0% in 2021, then tumbled by -6594bps to 21420.69% in 2022, then surged by 97bps to 707.69% in 2023, then tumbled by -193bps to 2076.22% in 2024, then tumbled by -80bps to 3735.06% in 2025.
- Its last three reported values are 3735.06% in Q3 2025, 1361.45% for Q2 2025, and 56.35% during Q1 2025.